M Ludwig

Summary

Country: Germany

Publications

  1. ncbi Pregnancy course and outcome after intracytoplasmic sperm injection: a controlled, prospective cohort study
    Alexander Katalinic
    Institute of Cancer Epidemiology and Institute for Social Medicine, , , Germany
    Fertil Steril 81:1604-16. 2004
  2. ncbi Developments in drugs for ovarian stimulation
    M Ludwig
    Department of Gynaecology and Obstetrics, Division of Reproductive Medicine and Gynaecologic Endocrinology, University Clinic, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Best Pract Res Clin Obstet Gynaecol 17:231-47. 2003
  3. ncbi Preimplantation genetic diagnosis: the German situation
    M Ludwig
    Dept of Gynecology and Obstetrics, University Clinic, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Trends Genet 17:473-4. 2001
  4. ncbi Ureteric and pulmonary endometriosis
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Germany
    Arch Gynecol Obstet 265:158-61. 2001
  5. ncbi Pregnancy course and health of children born after ICSI depending on parameters of male factor infertility
    Michael Ludwig
    Division of Reproductive Medicine, Department of Gynecology and Obstetrics, University Hospital, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Hum Reprod 18:351-7. 2003
  6. ncbi Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Germany
    Arch Gynecol Obstet 266:12-7. 2002
  7. ncbi Ovarian stimulation: from basic science to clinical application
    Michael Ludwig
    Division of Reproductive Medicine and Gynecologic Endocrinology, Department of Gynecology and Obstetrics, University Clinic, Lubeck, Germany
    Reprod Biomed Online 22:S3-16. 2011
  8. ncbi Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study
    M Ludwig
    Division of Reproductive Medicine and Gynecologic Endocrinology, Medical University Lubeck, Beckergrube 42 44, 23552 Lübeck, Germany
    Hum Reprod 17:2842-5. 2002
  9. ncbi Malformation rate in fetuses and children conceived after ICSI: results of a prospective cohort study
    Michael Ludwig
    Division of Reproductive Medicine and Gynecologic Endocrinology, Department of Gynecology and Obstetrics, University Hospital, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Reprod Biomed Online 5:171-8. 2002
  10. ncbi Follow-up of children born after assisted reproductive technologies
    Michael Ludwig
    Department of Gynecology and Obstetrics, University Clinic, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Reprod Biomed Online 5:317-22. 2002

Collaborators

Detail Information

Publications70

  1. ncbi Pregnancy course and outcome after intracytoplasmic sperm injection: a controlled, prospective cohort study
    Alexander Katalinic
    Institute of Cancer Epidemiology and Institute for Social Medicine, , , Germany
    Fertil Steril 81:1604-16. 2004
    ..An infertility-linked risk is highly probable for the observed findings. A technique-related risk, however, cannot be ruled out...
  2. ncbi Developments in drugs for ovarian stimulation
    M Ludwig
    Department of Gynaecology and Obstetrics, Division of Reproductive Medicine and Gynaecologic Endocrinology, University Clinic, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Best Pract Res Clin Obstet Gynaecol 17:231-47. 2003
    ....
  3. ncbi Preimplantation genetic diagnosis: the German situation
    M Ludwig
    Dept of Gynecology and Obstetrics, University Clinic, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Trends Genet 17:473-4. 2001
    ..Using this technique, there is an opportunity for couples who have an increased risk of transmitting severe genetic disorders to their offspring to reduce this risk by >95%. By doing PGD, abortions at a later stage can be avoided...
  4. ncbi Ureteric and pulmonary endometriosis
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Germany
    Arch Gynecol Obstet 265:158-61. 2001
    ..The patient was treated with gosereline acetate for six months (Zoladex). Control radiographs showed complete regression of the pulmonary lesions and the patient is symptom free at 36 months after diagnosis...
  5. ncbi Pregnancy course and health of children born after ICSI depending on parameters of male factor infertility
    Michael Ludwig
    Division of Reproductive Medicine, Department of Gynecology and Obstetrics, University Hospital, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Hum Reprod 18:351-7. 2003
    ..There is an ongoing debate as to whether the outcome of ICSI is affected by the origin of sperm used or by the severity of male factor infertility...
  6. ncbi Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Germany
    Arch Gynecol Obstet 266:12-7. 2002
    ..In the 2 mg group, the plasma concentrations fell to below limits of quantification in 8/9 samples on the day of ET. In 26 out of 27 FF samples cetrorelix was detectable in the 3 mg single dose group (median level: 0.69 ng/ml)...
  7. ncbi Ovarian stimulation: from basic science to clinical application
    Michael Ludwig
    Division of Reproductive Medicine and Gynecologic Endocrinology, Department of Gynecology and Obstetrics, University Clinic, Lubeck, Germany
    Reprod Biomed Online 22:S3-16. 2011
    ..The development of gonadotrophin-releasing hormone (GnRH) analogues and more recently the use of GnRH antagonists has helped to improve ovarian stimulation protocols by optimizing their efficacy, and making them easier to administer...
  8. ncbi Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study
    M Ludwig
    Division of Reproductive Medicine and Gynecologic Endocrinology, Medical University Lubeck, Beckergrube 42 44, 23552 Lübeck, Germany
    Hum Reprod 17:2842-5. 2002
    ....
  9. ncbi Malformation rate in fetuses and children conceived after ICSI: results of a prospective cohort study
    Michael Ludwig
    Division of Reproductive Medicine and Gynecologic Endocrinology, Department of Gynecology and Obstetrics, University Hospital, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Reprod Biomed Online 5:171-8. 2002
    ....
  10. ncbi Follow-up of children born after assisted reproductive technologies
    Michael Ludwig
    Department of Gynecology and Obstetrics, University Clinic, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Reprod Biomed Online 5:317-22. 2002
    ..Therefore, there are more infertility related problems than those related to technique. Finally, however, a risk related to the technique itself cannot be excluded completely by currently available data...
  11. ncbi Is intracytoplasmic sperm injection itself an indication to perform preimplantation genetic diagnosis (PGD)? About PGD, invasive prenatal diagnosis and genetic sonography
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Germany
    Fetal Diagn Ther 16:68-82. 2001
    ..e. high-resolution ultrasound with measurement of nuchal translucency at the end of the first trimester, and detailed fetal evaluation at 18-22 weeks of gestation...
  12. ncbi Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Lubeck, Germany
    Fertil Steril 75:18-22. 2001
    ..To summarize data from completed phase II and III clinical trials on children born after controlled ovarian stimulation using the luteinizing hormone-releasing hormone antagonist cetrorelix...
  13. ncbi Ovarian abscess and heterotopic triplet pregnancy: two complications after IVF in one patient
    M Ludwig
    Klinik fur Frauenheilkunde und Geburtshilfe, Medizinische Universitat zu Lubeck
    Arch Gynecol Obstet 263:25-8. 1999
    ..Bilateral salpingectomy was performed, because of bilateral haematosalpinx and previously described bilateral tubal occlusion. The further pregnancy was uncomplicated...
  14. ncbi No significant leukocytosis under controlled ovarian stimulation using the LHRH antagonist Cetrorelix and recFSH
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Ratzeburger Allee 160, 23538, Lubeck, Germany
    Eur J Obstet Gynecol Reprod Biol 89:177-9. 2000
    ....
  15. ncbi Heterotopic pregnancy in a spontaneous cycle: do not forget about it!
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Germany
    Eur J Obstet Gynecol Reprod Biol 87:91-3. 1999
    ..The pregnancy continued uneventfully and a healthy child was delivered at term. The problems, which lead to the misdiagnosis are discussed. The problem of rare cases in medicine, and the problems of a 'modern' medicine are discussed...
  16. ncbi Serum leptin concentrations throughout the menstrual cycle
    M Ludwig
    Department of Gynaecology and Obstetrics, Medical University of Lubeck, Germany
    Arch Gynecol Obstet 263:99-101. 2000
    ..50 +/- 8.75 ng/mL) (P < 0.02). A strongly positive correlation with the progression of the menstrual cycle could be seen (r = 0.91). The physiological significance of higher luteal phase leptin levels is unknown...
  17. ncbi [Possibilities and limits of assisted reproduction]
    M Ludwig
    Klinik fur Frauenheilkunde und Geburtshilfe, Medizinische Universitat zu Lubeck
    Gesundheitswesen 61:593-600. 1999
    ..The data on the success of ICSI, the known data on the newborn and developing children and the decisions of the medical services of the German statutory health insurance bodies are presented in discussed in this paper...
  18. ncbi Deep vein thrombosis during administration of HMG for ovarian stimulation
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Germany
    Arch Gynecol Obstet 263:139-41. 2000
    ..The patient was stimulated according to the long luteal protocol. Cases of arterial and venous thrombosis as a result of ovarian stimulations are reviewed...
  19. ncbi The situation of preimplantation genetic diagnosis in Germany: legal and ethical problems
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Prenat Diagn 20:567-70. 2000
    ..Because of these contradictions, legislation is required to clarify the legal status of PGD in Germany...
  20. ncbi Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction
    M Ludwig
    Klinik für Frauenheilkunde und Geburtshife, Medizinische Universisität Lÿbeck
    Arch Gynecol Obstet 264:29-32. 2000
    ..26%). The Cetrorelix multiple dose protocol is advantageous compared to the long protocol regarding the incidence of OHSS, a potentially life threatening complication of controlled ovarian stimulation...
  21. ncbi Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?
    J B Engel
    Division of Reproductive Medicine and Gynecologic Endocrinology, Department of Gynecology and Obstetrics, University Clinic, Ratzeburger Allee 160, , Germany
    Hum Reprod 17:2022-6. 2002
    ..CONCLUSIONS: Increasing the daily cetrorelix dose from 0.25 to 0.5 mg might decrease the number of premature LH surges. Soft stimulation protocols with clomiphene should be used cautiously...
  22. ncbi No influence of body weight on pregnancy rate in patients treated with cetrorelix according to the single- and multiple-dose protocols
    J B Engel
    Department of Gynecology and Obstetrics, University Clinic, , Germany
    Reprod Biomed Online 6:482-7. 2003
    ..Body weight does not influence the outcome of treatment in cetrorelix cycles...
  23. ncbi Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support
    M Ludwig
    Department of Gynecology and Obstetrics, , , Germany
    Acta Obstet Gynecol Scand 80:574-82. 2001
    ..CONCLUSION: Progesterone only for luteal phase support leads to the same clinical ongoing pregnancy rate as hCG, but has no impact on the comfort of the patient...
  24. ncbi Uterine artery Doppler velocimetry and the outcome of pregnancies resulting from ICSI
    A Geipel
    Department of Obstetrics and Gynecology, University Medical School, Medical University of Lubeck, Ratzeburger Allee 233, D 23538 Lubeck, Germany
    Hum Reprod 16:1397-402. 2001
    ..An increased incidence of pregnancy complications following assisted reproduction has been reported. The use of uterine artery Doppler ultrasound may aid the prediction of such complications...
  25. ncbi Preparation of cycles for cryopreservation transfers using estradiol patches and Crinone 8% vaginal gel is effective and does not need any monitoring
    C Banz
    Department of Gynecology and Obstetrics, University Hospital, Ratzeburger Allee 160, , Germany
    Eur J Obstet Gynecol Reprod Biol 103:43-7. 2002
    ..The estradiol serum level did not predict success. In conclusion, this method of endometrial preparation is comfortable for patients and monitoring is unnecessary...
  26. ncbi Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study
    M Ludwig
    Department of Gynecology and Obstetrics, Medical University of Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur J Obstet Gynecol Reprod Biol 103:48-52. 2002
    ..05). Twenty patients familiar with the alternative preparation from a previous cycle also noted that Crinone 8% was easier to apply (P < 0.01) and less time consuming (P < 0.05) to use than Utrogest...
  27. ncbi Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients
    A K Schröder
    Department of Gynaecology and Obstetrics, University Clinic Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Reprod Biomed Online 8:600-6. 2004
    ..The drop-out rate should be used as an important marker of quality control. The presented data give, for the first time, a good basis for this counselling procedure in Germany...
  28. ncbi The value of pronuclear scoring for the success of IVF and ICSI-cycles
    A K Ludwig
    Department of Gynecology and Obstetrics, University Clinic Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Arch Gynecol Obstet 273:346-54. 2006
    ..Pronuclear scoring helps to identify good quality embryos already at the pronuclear stage. There are no data available, however, to demonstrate whether patients benefit from a higher pregnancy rate after pronuclear scoring...
  29. ncbi Post-neonatal health and development of children born after assisted reproduction: a systematic review of controlled studies
    A K Ludwig
    Department of Gynaecology and Obstetrics, University of Schleswig Holstein, Campus Lubeck, Germany
    Eur J Obstet Gynecol Reprod Biol 127:3-25. 2006
    ..However, low birth weight and prematurity contributes to health care problems. An increase of neurological problems by IVF cannot be excluded. Further prospective studies on the neurological outcome are needed...
  30. ncbi Counselling on cryopreservation of pronucleated oocytes
    A K Schröder
    Department of Gynecology and Obstetrics, University Clinic Hospital, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Reprod Biomed Online 6:69-74. 2003
    ..Therefore, cryopreservation of pronucleate eggs with a higher developmental potential is possible. The total pregnancy rate could be raised from 28.0 to 35.5% per fresh transfer cycle...
  31. ncbi Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis
    M Ludwig
    Division of Reproductive Medicine and Gynecologic Endocrinology, Department of Gynecology and Obstetrics, University Clinic, , Germany
    Arch Gynecol Obstet 265:175-82. 2001
    ..Several possibilities to explain this phenomenon are discussed...
  32. ncbi Antenatal care in singleton pregnancies after ICSI as compared to spontaneous conception: data from a prospective controlled cohort study in Germany
    A K Ludwig
    Department of Gynaecology and Obstetrics, Institute of Cancer Epidemiology, University of Schleswig Holstein, Campus Lubeck, Germany
    Hum Reprod 21:713-20. 2006
    ..The aim was to compare the antenatal care and the intake of vitamins and medications of infertility patients with singleton pregnancies after ICSI to women with a spontaneously conceived singleton pregnancy...
  33. ncbi Clinical application of GnRH-antagonists
    R E Felberbaum
    Department of Obstetrics and Gynecology, Medical University of Lubeck, Ratzeburger Allee 160, 23538, Lubeck, Germany
    Mol Cell Endocrinol 166:9-14. 2000
    ..Suitable sustained delivery systems and the development of GnRH-antagonists with sufficient oral bioavailability, represent the present and future challenge for these efforts...
  34. ncbi Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals
    A K Ludwig
    Department of Gynaecology and Obstetrics, University of Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, Lubeck 23538, Germany
    Hum Reprod 21:3235-40. 2006
    ..Although transvaginal ultrasound-guided oocyte retrievals (OR) are performed routinely worldwide, there is very little systematic data about its complications...
  35. ncbi Antenatal corticosteroid therapy in premature infants
    J M Smrcek
    Division of Prenatal Medicine, Department of Obstetrics and Gynecology, Medical University of Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Arch Gynecol Obstet 271:26-32. 2005
    ..The objective was to examine the effect of antenatal corticosteroid treatment on premature infants, with special attention to any possible adverse effects on neonatal outcome...
  36. ncbi Tuberculous epididymo-orchitis and prostatitis: a case report
    M Ludwig
    Urological Practice A von Keitz, M Schwickardi and M Ludwig, Marburg, Germany
    Andrologia 40:81-3. 2008
    ..The treatment of choice is primarily medical, consisting of a combination of three or four anti-TB drugs, sometimes combined with surgery...
  37. ncbi Diagnosis and therapy of acute prostatitis, epididymitis and orchitis
    M Ludwig
    Urological Practice A von Keitz, M Schwickardi and M Ludwig, Marburg, Germany
    Andrologia 40:76-80. 2008
    ..In contrast to these diseases, acute primary orchitis is a rare event, mostly occurring as mumps orchitis, without standardised treatment guidelines...
  38. ncbi [Recurrent urinary tract infection in women. Long-term antibiotic prophylaxis]
    M Ludwig
    Urologische Praxis Dres A von Keitz, M Schwickardi, M Ludwig, Marburg
    Urologe A 45:436-42. 2006
    ..Given the correct indications, the recurrence rate of rUTI can be reduced by 95%...
  39. ncbi Germ cell migration and early development of the gonads in the trisomy 16 mouse--an animal model for Down's syndrome
    A Leffler
    Department of Anatomy, Medical University of Lubeck, Germany
    Ann Anat 181:247-52. 1999
    ....
  40. ncbi Urogenital infection and sperm motility
    T Diemer
    Department of Urology, University Hospital, Justus-Liebig-University Giessen, Germany
    Andrologia 35:283-7. 2003
    ..This review will focus in detail on direct bacterial effects of sperm motility, the role of seminal leucocytes and the impact of pro-inflammatory cytokines on the motility of spermatozoa...
  41. ncbi Factors influencing response to ovarian stimulation
    Christoph Keck
    Serono International, Geneva, Switzerland
    Reprod Biomed Online 11:562-9. 2005
    ..This is an important step towards further minimizing drug-related variability of ovarian response to FSH treatment...
  42. ncbi Reproduction abnormalities and twin pregnancies in parents of sporadic patients with oculo-auriculo-vertebral spectrum/Goldenhar syndrome
    Dagmar Wieczorek
    Institut fur Humangenetik, Universitatsklinikum Essen, Universitat Duisburg Essen, Hufelandstr 55, 45122, Essen, Germany
    Hum Genet 121:369-76. 2007
    ..0025). An excess of ART conceptions and monozygotic twinning in OAVS is compatible with the concept of overripeness ovopathy as proposed by Jongbloet (Maandschr Kindergeneeskd 36:352-367, 1968)...
  43. ncbi Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilizatio
    Nicole G M Beckers
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands
    J Clin Endocrinol Metab 88:4186-92. 2003
    ..Hence, support of corpus luteum function remains mandatory after ovarian stimulation for IVF with GnRH antagonist cotreatment...
  44. ncbi Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle
    Anna Sophie Seelig
    Department of Gynecology and Obstetrics, University Clinic Hospital, Lubeck, Germany
    Fertil Steril 77:472-5. 2002
    ....
  45. ncbi GnRH antagonists in the treatment of infertility
    Jürgen M Weiss
    Department of Gynecology and Obstetrics, Medical University Luebeck, Luebeck, Germany
    Ann Med 35:512-22. 2003
    ..e., the GnRH agonist long protocol. However, especially the effectiveness of these compounds will have to be clarified in the near future by carefully designed prospective, randomized studies...
  46. ncbi Use of recombinant human chorionic gonadotropin in ovulation induction
    Michael Ludwig
    Reproductive Medicine and Gynecologic Endocrinology, Endokrinologikum Hamburg, Hamburg, Germany
    Fertil Steril 79:1051-9. 2003
    ....
  47. ncbi Use of clomiphene citrate in in vitro fertilization (IVF) and IVF/intracytoplasmic sperm injection cycles
    Klaus Fiedler
    Fertil Steril 80:1521-3. 2003
  48. ncbi Distribution of persistent organochlorine contaminants in infertile patients from Tanzania and Germany
    Jürgen M Weiss
    Department of Obstetrics and Gynecology, University Clinic Luebeck, Ratzeburger Allee 160, D 23538, Luebeck, Germany
    J Assist Reprod Genet 23:393-9. 2006
    ..To test whether environmental pollutants could affect fertility in humans...
  49. ncbi Exclusion of WTAP and HOXA13 as candidate genes for isolated hypospadias
    Boris Utsch
    Children s Hospital Medical Center, University of Bonn, Germany
    Scand J Urol Nephrol 37:498-501. 2003
    ....
  50. ncbi The usefulness of a thyrotropin-releasing hormone stimulation test in subfertile female patients
    Michael Ludwig
    Endokrinologikum Hamburg, Zentrum für Hormon und Stoffwechselerkrankungen, Reproduktionsmedizin und Gynäkologische Endokrinologie, Hamburg, Germany
    Gynecol Endocrinol 23:226-30. 2007
    ..However, its usefulness in daily clinical practice has not been proven, despite more than 30 years of use...
  51. ncbi Successful assisted reproduction in adult males with bladder extrophy-epispadias complex
    Lisa Gambhir
    Eur J Obstet Gynecol Reprod Biol 139:259-60. 2008
  52. ncbi Outcome of assisted reproduction
    Alastair G Sutcliffe
    Department of Paediatrics, University College London, London, UK
    Lancet 370:351-9. 2007
    ..No increase in discord or other difficulties within families has been recorded. Long-term follow-up of children born after ART to reproductive age and beyond is necessary...
  53. ncbi Concordance analyses of twins with bladder exstrophy-epispadias complex suggest genetic etiology
    Heiko Reutter
    Department of Human Genetics, University of Bonn, Bonn, Germany
    Am J Med Genet A 143:2751-6. 2007
  54. ncbi What can we expect if we measure hormones in eumenorrhoeic infertile patients?
    Frank Nawroth
    Endokrinologikum Hamburg, Zentrum für Hormon und Stoffwechselerkrankungen, Reproduktionsmedizin und Pränatale Medizin, Lornsenstrasse 4 6, 22767 Hamburg, Germany
    Reprod Biomed Online 16:621-6. 2008
    ..The paper discusses the questions on the basis of the currently available literature...
  55. ncbi Allopregnanolone serum levels and expression of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy
    Birgit Stoffel-Wagner
    Department of Clinical Biochemistry, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany
    Epilepsy Res 54:11-9. 2003
    ..These findings provide further molecular biological evidence for the formation and metabolism of neuroactive steroids in the human brain...
  56. ncbi Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain
    Stephan Steckelbroeck
    Department of Pharmacology, University of Pennsylvania School of Medicine, 130C John Morgan Building, 3620 Hamilton Walk, Philadelphia, PA 19104 6084, USA
    J Steroid Biochem Mol Biol 86:79-92. 2003
    ....
  57. ncbi Development of children born after IVF and ICSI
    Michael Ludwig
    Endokrinologikum Hamburg, Zentrum für Hormon und Stoffwechselerkrankungen, Gynäkologische Endokrinologie und Reproduktionsmedizin, Lornsenstrasse 6, 22767 Hamburg, Germany
    Reprod Biomed Online 9:10-2. 2004
    ..However, there are some limitations for all these follow-up studies, which have to be taken into account, when interpreting results. These are discussed in this commentary...
  58. ncbi What is the 'ideal' duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen/progesterone replacement protocols?
    Frank Nawroth
    Endokrinologikum Hamburg, Zentrum für Hormon und Stoffwechselerkrankungen, Reproduktionsmedizin und Gynäkologische Endokrinologie, Germany
    Hum Reprod 20:1127-34. 2005
    ..If this is so, we must look for practicable methods to modify the protocols according to the individual patient, the embryonic developmental stage during transfer and other variables...
  59. ncbi Gonadotropin-releasing hormone antagonists: pharmacology and clinical use in women
    Juergen M Weiss
    Department of Gynecology and Obstetrics, Medical University of Luebeck, Luebeck, Germany
    Treat Endocrinol 1:281-91. 2002
    ..This broadens the spectrum of indications for GnRH antagonists to sex hormone-dependent disorders like endometriosis, uterine fibroids, and gynecological cancers such as breast and ovarian cancer...
  60. ncbi Functional evaluation of Dent's disease-causing mutations: implications for ClC-5 channel trafficking and internalization
    Michael Ludwig
    Institut für Klinische Biochemie, Universitat Bonn, Sigmund Freud Strasse 25, 53105 Bonn, Germany
    Hum Genet 117:228-37. 2005
    ..Our observations further imply that recruitment of ClC-5 to alternative routes (plasma membrane or early endosomes) in the trans-Golgi network is mediated via different signal sequences...
  61. ncbi Does the addition of luteinizing hormone in ovarian stimulation protocols improve the outcome?
    Michael Ludwig
    Centre of Reproductive Medicine and Gynecologic Endocrinology, Endokrinologikum Hamburg, Hamburg, Germany
    Treat Endocrinol 2:305-13. 2003
    ..However, more data are necessary before evidence-based recommendations regarding LH supplementation in ovarian stimulation protocols can be given...
  62. ncbi Assisted reproduction: the epigenetic perspective
    Bernhard Horsthemke
    Institut fur Humangenetik, Universitatsklinikum Essen, Essen, Germany
    Hum Reprod Update 11:473-82. 2005
    ..In addition, loss of epigenetic control may expose hidden genetic variation...
  63. ncbi Intraamniotic ethacridine lactate instillation versus vaginal PGE1 in second trimester termination of pregnancy
    Christoph Berg
    Department of Obstetrics and Prenatal Medicine, Center for Obstetrics and Gynecology, Rheinische Friedrich Wilhelms Universitat, Sigmund Freud Str 25, 53105 Bonn, Germany
    Eur J Obstet Gynecol Reprod Biol 126:193-6. 2006
    ..To report on our experience with intraamniotic injection of ethacridine lactate (EL) for second trimester termination of pregnancy (TOP) and to compare its effectiveness with vaginal PGE1 in this setting...
  64. ncbi Are major defects in children conceived in vitro due to innate problems in patients or to induced genetic damage?
    Robert G Edwards
    Reproductive BioMedicine Online, Duck End Farm, Dry Drayton, Cambridge CB3 8DB, UK
    Reprod Biomed Online 7:131-8. 2003
    ..Various genetic and developmental factors in infertile couples influencing the origin of such birth outcomes are assessed, and the significance of imprinting and its embryological roles are discussed...
  65. ncbi Risk during pregnancy and birth after assisted reproductive technologies: an integral view of the problem
    Michael Ludwig
    Endokrinologikum Hamburg, Zentrum für Hormon und Stoffwechselerkrankungen, Gynäkologische Endokrinologie und Reproduktionsmedizin, Hamburg, Germany
    Semin Reprod Med 23:363-70. 2005
    ..A long time to pregnancy with subsequent spontaneous pregnancy results in a similar risk profile as pregnancies following infertility treatment. This article discusses a possible pathogenetic model for these observations...
  66. ncbi Is women's health endangered by the German Embryo Protection Law?
    Michael Ludwig
    Centre for Reproductive Medicine and Gynaecologic Endocrinology, Endokrinologikum Hamburg, Lornsenstrasse 6, 22767 Hamburg, Germany
    Curr Womens Health Rep 3:349-50. 2003
  67. ncbi The process of decision making in reproductive medicine
    Annika K Ludwig
    Department of Gynecology and Obstetrics, University Clinic Schleswig Holstein, Campus Lubeck, Lubeck, Germany
    Semin Reprod Med 23:348-53. 2005
    ..Couples who have undergone at least six IVF cycles should be counseled to discontinue therapy. The treatment program should be as individualized as possible, with individual counseling that is adapted after each single treatment cycle...